Questions across 3 calls

Harshal Patil

Mirae Asset Capital Market

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited CC-Aug25.pdf · 2025-07-28

Good evening, sir. And thanks for the opportunity. Sir, just one clarification, you did earlier say that out of the revenue per test increase, about 1% to 1.5% would be largely attributable to some price increases. So, I presume that this would be ideally done in some select pocket or some select category of tests for this quarter. So, would that be the right assumption?

So, going ahead, I believe like further price hikes, or something should be possible or shouldn't be possible? I mean, considering that we have taken for some select tests only.

Laurus Labs Limited

Analysts/Institutional Investor Meet/Con. Call Updates Laurus Labs Limited has informed the Exchange about Transcript · 2024-07-25

Sir, just had one clarification. For the PPTs, if I have to refer to the API PPT slide, there's a comment which says that overall sequential decline due to timing of shipments particularly. So, is there any problem that we faced, any logistical issue that we faced? And do you see this more as a transient thing or what?

But is it at least transient in nature? So, we can expect the normalcy to be retained?

Laurus Labs Limited CC-Jun24.pdf · 2024-07-25

Sir, just had one clarification. For the PPTs, if I have to refer to the API PPT slide, there's a comment which says that overall sequential decline due to timing of shipments particularly. So, is there any problem that we faced, any logistical issue that we faced? And do you see this more as a transient thing or what?

But is it at least transient in nature? So, we can expect the normalcy to be retained?